Green Valley Drugs: Recall of All Lots of All Sterile Products - Quality Control Concerns
Lack of sterility assurance and concerns associated with quality control processes.
Undefined
Lack of sterility assurance and concerns associated with quality control processes.
Potential Health Risk - contains sildenafil
When used with some remote nurse alarm systems and may cause serious adverse health consequences, including death.
Lab tests revealed the product contains an analogue of sildenafil, which may interact with nitrates found in prescription drugs such as nitroglycerin, and lower blood pressure to dangerous levels.
L’Agenzia Italiana del Farmaco, in accordo con l’Agenzia Europea dei
Medicinali (EMA), rende disponibile on line nuove ed importanti
informazioni sul rischio di secondi tumori primari ematologici nei pazienti trattati con Talidomide.
Use of recalled device may lead to unintended delivery of insulin, placing patients in danger of potential serious health risks, such as hypoglycemia.
During routine inspection, one lot showed presence of visible particles.
L’Agenzia
Italiana del Farmaco, in accordo con l’Agenzia Europea dei Medicinali, rende
disponibili on line importanti informazioni riguardanti la gestione delle Reazioni Avverse Cutanee
Gravi (SCAR) associate a INCIVO (telaprevir).
L’Agenzia Italiana del Farmaco, in accordo con l’Agenzia Europea dei Medicinali (EMA), rende disponibile on line nuove ed importanti informazioni su Relpax (Eletriptan bromidrato).
Administration of solution containing brass particulate may result in occlusion of small blood vessels, copper toxicity, hemolysis and liver toxicity, or hepatic necrosis which may be fatal.
80.211.154.110